Bravelle Class-Action Lawsuit Filed

Holtsville, NY: Ferring Pharmaceuticals, maker of Bravelle fertility drug, faces a class-action lawsuit alleging its drug was weaker than patients believed. The lawsuit alleges the ineffective drug prevented couples from becoming pregnant and drained their finances, making it impossible to afford another round of fertility treatments. Lawsuits have been filed in the United States and Canada by couples who allege the recalled Bravelle affected their hopes of having a baby